Targeting the insulin-like growth factor-1 receptor in human cancer.
about
Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung CancerGrowth factor and signaling pathways and their relevance to prostate cancer therapeuticsInsulin-like growth factor system in cancer: novel targeted therapiesIGF-IR Targeted Therapy: Past, Present and FutureIndirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activityNovel tools for prostate cancer prognosis, diagnosis, and follow-upUpdate of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapyRole of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferationInsulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.Silencing of insulin-like growth factor-1 receptor enhances the radiation sensitivity of human esophageal squamous cell carcinoma in vitro and in vivoIGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).Regulation of IGF -1 signaling by microRNAs.The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy.IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: Role of epigenetic regulation.Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells.Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospects.Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer.Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.Lamellar events related to insulin-like growth factor-1 receptor signalling in two models relevant to endocrinopathic laminitis.Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination StudiesProteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways.Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors.PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.Target identification of grape seed extract in colorectal cancer using drug affinity responsive target stability (DARTS) technique: role of endoplasmic reticulum stress response proteins.Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway.Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer.Insulin-like growth factor 1 receptor inhibitors: where do we come from? What are we? Where are we going?The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications.Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells.Co-expression of Dsb proteins enables soluble expression of a single-chain variable fragment (scFv) against human type 1 insulin-like growth factor receptor (IGF-1R) in E. coli.Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression
P2860
Q26740210-47A3469D-B36C-458B-AF31-BD319EFF0CD6Q26827975-0A409B7E-883C-41A2-8064-D54C258C3B35Q28081603-D592E2CC-06F8-4C24-9135-4C681A178053Q28082127-4CF19E3C-1551-44DC-9A76-874041F81F16Q33572235-D3D8BE83-2831-4821-9230-9D879704263AQ33625338-8E9952BA-7C9D-4142-B8B7-C341B1839F46Q33710179-A6839146-A766-4358-94D5-C436F7079E2CQ33817206-E6F1A423-384F-44B7-B016-29ECEF7C78F5Q34110523-9297453C-7ACD-487B-93A6-1CABD87D53AAQ34515394-AC2FC858-9EA6-4319-923B-87DA75CC57F1Q34556695-E284C602-E0FE-4491-876B-4C0A7BB9358CQ34936657-3714F3A9-EEEA-4951-8102-47CCC6F3DF73Q35030616-A990A317-DAE0-43A3-90B0-F598EF13A1DEQ35894540-3EC26AD2-A564-48C4-8A23-6CDF4A9CA716Q36083412-BD8000DD-A00D-40A4-868B-7D3F41CD6E6BQ36238242-43CEDE18-FF7A-48B9-9809-F5F4D8BEBC16Q36685485-C6FC817A-944F-4660-8A09-F1D533760EEBQ37334160-19EE8A12-9DE7-4FAB-8681-294A40877F61Q37694781-97ED0A10-B94F-4C0A-8079-BA99DAFFE2E8Q38289429-44C5BA94-54B8-4C02-9DD6-3535B96B9106Q38641329-93C7C6D3-7DD9-428F-B40B-99F9B2465C8DQ38760614-47A46CF0-1EB0-420F-B3E7-83122CC12B4EQ38869428-9A58C68E-04E8-4434-923C-9CF7FB2DCEC7Q38889580-FD90D488-AB2C-482A-84ED-B871E42E2105Q39005127-64900D02-96C9-46F2-B439-F5D2FEEDA1CAQ39028976-8E44B8B9-E31C-4290-9C58-63090FBA2A59Q40471080-018CF813-5888-4B20-BE36-CF487FCE513DQ42561379-6002A7A1-F83D-41AC-ABFE-14B357D4BC36Q44582020-32A8BE52-91B7-4CB4-B9CE-FC7CE301C7B9Q47138434-8CDA91CF-176F-4766-8ABF-BAD8B870B7C0Q47435335-75B71614-A5CF-4A3C-820F-62D6F44ECF22Q53434131-C499AE9C-DABE-44A0-8A70-212AB4EE7AC6Q56968081-0EF0AC30-853F-4499-BD82-1912D43A7499
P2860
Targeting the insulin-like growth factor-1 receptor in human cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Targeting the insulin-like growth factor-1 receptor in human cancer.
@ast
Targeting the insulin-like growth factor-1 receptor in human cancer.
@en
type
label
Targeting the insulin-like growth factor-1 receptor in human cancer.
@ast
Targeting the insulin-like growth factor-1 receptor in human cancer.
@en
prefLabel
Targeting the insulin-like growth factor-1 receptor in human cancer.
@ast
Targeting the insulin-like growth factor-1 receptor in human cancer.
@en
P2860
P356
P1476
Targeting the insulin-like growth factor-1 receptor in human cancer.
@en
P2093
Alexandre Arcaro
P2860
P356
10.3389/FPHAR.2013.00030
P577
2013-03-22T00:00:00Z